By contrast the phosphorylation of NFκB on S468 was largely unaffected by the inhibitor in the NSCLC cell lines but was reduced in type II pneumocytes (Fig. 6B) and in A549 cells (S4 Figure). Here, NFKB1 is linked to non-small cell lung carcinoma.